CMV colitis

Revision as of 21:54, 4 January 2026 by Ostermayer (talk | contribs) (Prepared the page for translation)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Background

  • CMV is part of the Herpesviridae family
  • 50-80% of the world's population is seropositive for CMV
  • Causes a mild or undetectable infection in immunocompetent hosts
  • Severe systemic illness is found in immunosuppressed hosts


Clinical Features


Differential Diagnosis

Colitis

CMV Diseases


Evaluation

Management

  • Ganciclovir 5mg/kg IV q12hrs x 21 days (or until resolution of symptoms)
  • Foscarnet 90mg/kg IV q12hrs daily x 21 days (or until resolution of symptoms)


Disposition

See Also


External Links

References